Puration Cannabis-Extracts Sex Drugs Soda Cheetos Rock n Roll and a Rocket PPS
Even Motley Fool Is (Kinda) Bullish On MJ (With Professionally Worded Disclaimers)
Austin, Texas – July 19, 2016 – Wolf Wrangler is growing fonder of Puration, Inc.’s (PURA) cannabis extraction business plan every day. Smoking marijuana is fine, but infusing marijuana extracts into consumer products is where we think the big money will be found. After working on standardizing a repeatable process to produce consistently high quality extract over the past year, Puration is just now bringing their progress and go forward plans to light.
First Puration announces a crystalized CBD extract. Mark our words here, crystalized extracts are going to be hot and Puration is way ahead of the curve.
Then the Company CEO. Brian Shibley puts out an educational presentation on what cannabis extracts are all about, particularly THC, and details the current and future market opportunity for cannabis extracts … and you’ve got to love the title of his presentation:
Last week, the Company put out a preliminary $3m forecast for the next 12 months to be derived from the sale Puration Extracts, and yesterday they publish a detailed business plan explanation of how their Puration Extractions brand strategy drives their $3 million in revenue and how it might even turn out to be more revenue.
So we spent a little time independently looking at the market opportunity to infuse cannabis extractions into consumer products. Puration is definitely on the right track with their plan to brand Puration as the leading consistently high-quality extract in existing food and beverage consumer products. In fact, we hope they open their horizon to other consumer products.
Get this, MassRoots has recently featured some intriguing articles on potential cannabis infused consumer products outside the food and beverage industry:
Cosmopolitan, of course, has a predictably “intriguing” angle on the potential for cannabis infused products that appeal to their readers
We have our fingers crossed for Puration to come up with a cannabis infused lotion that enhances size or sensation or drive (or all of the above) where and when it counts. Talk about making a share price go up.
While Motley Fool tries their best to be “professionally” well-tempered about the marijuana sector highlighting fundamental indicators that should discourage investors, even they can’t help being (kinda) bullish. After presidential hopeful Governor John Kasich signed House Bill 523 into law making Ohio the 25th state to legalize medical marijuana, Motely Fool published the mostly upbeat article titled “Hello to the 25th and Newest State a to Legalize Medical Marijuana.” The highbrow folks at the Motley Fool concentrated their article largely on the Pharmaceutical applications of marijuana featuring GW Pharmaceuticals (GWPH), and they did so mostly in a positive manner (all good info, but we enjoy the more fun applications). The Motley Fool crew, of course, concluded the article with professionally worded fundamental industry warnings - as though marijuana sector performance is following any fundamentals.
With only 50 million shares issued and out; a year of quietly developing standardized and repeatable extraction processes to produce consistently high quality cannabis concentrates, and now introducing a smart go to market plan to brand their extracts … in light of a seemingly infinite number of opportunities to collaboratively infuse their extracts into existing consumer products, we think this PPS has the opportunity to rocket to the moon.
Wolf Wrangler Website:
Wolf Wrangler Facebook:
Wolf Wrangler Twitter:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.